Safety and pharmacokinetics

Clinical trials for Safety and pharmacokinetics explained in plain language.

Never miss a new study

Get alerted when new Safety and pharmacokinetics trials appear

Sign up with your email to follow new studies for Safety and pharmacokinetics, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New russian drug fluorothiazinone enters first human safety tests

Knowledge-focused Not yet recruiting

This early-stage trial will test the safety of a new drug called fluorothiazinone in 70 healthy adults aged 18 to 45. Participants will receive either a single dose or a short course of the drug or a placebo. The main goal is to check for side effects and how the drug moves throu…

Matched conditions: SAFETY AND PHARMACOKINETICS

Phase 1 • Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:51 UTC

Safety and pharmacokinetics

Get alerted when new Safety and pharmacokinetics trials appear

New russian drug fluorothiazinone enters first human safety tests